Results

1–10 of 30 results for Intravitreal Injections

Endophthalmitis After Intravitreal Injections with 0.05% Aqueous Chlorhexidine vs 5% Povidone-Iodine as Ocular Antiseptics
Murtaza K Adam, MD
Annual Meeting Talks
2022
Noninferiority of 1.7% Povidone–Iodine for Endophthalmitis Prophylaxis After Intravitreal Injections Compared With 5% Povidone–Iodine in an Office Setting
Kamal Kishore, MD, MBBS
Annual Meeting Talks
2022
Effect of Meditation on Perception of Pain, Anxiety, and Patient Satisfaction During Intravitreal Injections
On Demand Cases, Courses, and Papers
2022
Quality Assessment of a New Silicone-Free Syringe Developed for Intravitreal Injections
Gustavo Barreto de Melo, MD, PhD, FASRS
On Demand Cases, Courses, and Papers
2021
Board-Certified Providers Are Associated With a Reduced Risk of Endophthalmitis After Intravitreal Injections
Geoffrey G. Emerson, MD, PhD, FASRS
Annual Meeting Talks
2021
Bacterial Dispersion Associated With Various Patient Face Mask Designs During Simulated Intravitreal Injections
Samir N Patel, MD
Annual Meeting Talks
2021
The Conundrum of Intravitreal Injections and Use of -25 Modifier for Same-Day Office Visits
John T. Thompson, MD
Annual Meeting Talks
2021
Investigation of Microbial Content of Face Masks Used by Patients Receiving Intravitreal Injections
Avinash V Honasoge, MD, PhD
Annual Meeting Talks
2021
Low Incidence of Endopthalmitis After Intravitreal Injections in an Office Setting Without Gloves and Drapes With a Modified Technique
Kamal Kishore, MD, MBBS
On Demand Cases, Courses, and Papers
2020
Assessment of Online Websites Reliability, Content, and Readability for Intravitreal Injections
Nadim M Rayess, MD
On Demand Cases, Courses, and Papers
2020